Key result
Vein of Marshall ethanol infusion shows promise for managing AF by targeting the arrhythmogenic ligament.
Why the study?
The ligament of Marshall can trigger, sustain, or modulate atrial arrhythmias and undermine conventional ablation lines, prompting new therapies targeting this region.
Design
Review
Draft 1: While anatomically sound, routine adoption for AF ablation should wait;.
Researchers commonly regard the ligament of Marshall (LoM), an embryologic remnant of the left superior vena cava (LSVC), as a vestigial structure. However, despite its vestigial origin, the LoM retains functionally significant myocardial fibers, autonomic nerves, and venous elements. These muscular and neural components give LoM the capacity to trigger, sustain, or modulate atrial arrhythmias, particularly atrial fibrillation (AF). Recent studies have demonstrated that the LoM can serve as both an arrhythmogenic focus and a substrate for reentry, and its epicardial connections may undermine conventional ablation lines. Hence, researchers have developed new therapies to target this region. This review summarizes the anatomy, embryology, and electrophysiological properties of the LoM. It evaluates the clinical impact of Marshall complex targeted therapies, including vein of Marshall ethanol infusion (VoM-EI), in contemporary AF management.
No takes yet. Share an insight, caveat, or question.
Ayush Bhadreshkumar Patel (2026) studied this question. Vein of Marshall ethanol infusion targeting the ligament of Marshall shows promise in managing atrial fibrillation by addressing its arrhythmogenic role.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: